{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:09:04Z","timestamp":1768777744251,"version":"3.49.0"},"reference-count":39,"publisher":"Bentham Science Publishers Ltd.","issue":"5","funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFC1605700"],"award-info":[{"award-number":["2019YFC1605700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The purification of expressed proteins is the most critical part of subunit--\nvaccine production. Protein-purification methods such as affinity chromatography and ion\nexchange still have the shortcomings of being time consuming and complicated. With the rapid development\nof computational molecular-simulation technology, structure-based peptide-ligand design\nhas become feasible.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objection:<\/jats:title>\n<jats:p> We aimed to apply molecular docking for a peptide ligand designed for classical swine fever virus (CSFV) E2\npurification.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Computational-derived peptides were synthesized, and the in vitro binding interaction\nwith E2 was investigated. The effects of purification on E2 were also evaluated.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The best peptide recognizing E2 was P<jats:sub>6<\/jats:sub>, which had a sequence of KKFYWRYWEH.\nBased on kinetic surface plasmon resonance (SPR) analysis, the apparent affinity constant of P6\nwas found to be 148 nM. Importantly, P<jats:sub>6<\/jats:sub> showed suitable binding affinity and specificity for E2 purification\nfrom transgenic rice seeds. Evaluation of immune antibodies in mice showed that the antibody-\nblocking rate on day 42 after inoculation reached 86.18% and 90.68%.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The computational-designed peptide in this study has high sensitivity and selectivity\nand is thus useful for the purification of CSFV E2. The novel method of design provided a broad\nplatform and powerful tool for protein-peptide screening, as well as new insights into CSFV\nvaccine design.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929866527666201103152100","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T04:07:32Z","timestamp":1604462852000},"page":"554-562","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Purification of Classical Swine Fever Virus E2 Subunit Vaccines Based on High Affinity Peptide Ligand"],"prefix":"10.2174","volume":"28","author":[{"given":"Fangyu","family":"Wang","sequence":"first","affiliation":[{"name":"Henan Key Laboratory for Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002,China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuying","family":"Yu","sequence":"additional","affiliation":[{"name":"College of Food Science and Technology, Henan Agricultural University, Zhengzhou 450002,China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Hu","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory for Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002,China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangxu","family":"Xing","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory for Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002,China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory for Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002,China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaiping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory for Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002,China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0042-6822(03)00192-2","volume":"311","author":"Becher P.","year":"2003","unstructured":"Becher P.; Avalos Ramirez R.; Orlich M.; Cedillo Rosales S.; K&#xF6;nig M.; Schweizer M.; Stalder H.; Schirrmeier H.; Thiel H.J.; Genetic and antigenic characterization of novel pestivirus genotypes: implications for classification. Virology 2003,311(1),96-104","journal-title":"Virology"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0065-3527(08)60734-4","volume":"47","author":"Meyers G.","year":"1996","unstructured":"Meyers G.; Thiel H.J.; Molecular characterization of pestiviruses. Adv Virus Res 1996,47,53-118","journal-title":"Adv Virus Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.virol.2013.01.013","volume":"438","author":"Leifer I.","year":"2013","unstructured":"Leifer I.; Ruggli N.; Blome S.; Approaches to define the viral genetic basis of classical swine fever virus virulence. Virology 2013,438(2),51-55","journal-title":"Virology"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1099\/0022-1317-80-5-1157","volume":"80","author":"Weiland F.","year":"1999","unstructured":"Weiland F.; Weiland E.; Unger G.; Saalmuller A.; Thiel H.J.; Localization of pestiviral envelope proteins E(rns) and E2 at the cell surface and on isolated particles. J Gen Virol 1999,80(5),1157-1165","journal-title":"J Gen Virol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"6479","DOI":"10.1128\/JVI.69.10.6479-6486.1995","volume":"69","author":"K&#xF6;nig M.","year":"1995","unstructured":"K&#xF6;nig M.; Lengsfeld T.; Pauly T.; Stark R.; Thiel H.J.; Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J Virol 1995,69(10),6479-6486","journal-title":"J Virol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0264-410X(00)00198-5","volume":"19","author":"van Gennip H.G.","year":"2000","unstructured":"van Gennip H.G.; van Rijn P.A.; Widjojoatmodjo M.N.; de Smit A.J.; Moormann R.J.; Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response. Vaccine 2000,19(4-5),447-459","journal-title":"Vaccine"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"11619","DOI":"10.1128\/JVI.74.24.11619-11625.2000","volume":"74","author":"Lin M.","year":"2000","unstructured":"Lin M.; Lin F.; Mallory M.; Clavijo A.; Deletions of structural glycoprotein E2 of classical swine fever virus strain alfort\/187 resolve a linear epitope of monoclonal antibody WH303 and the minimal N-terminal domain essential for binding immunoglobulin G antibodies of a pig hyperimmune serum. J Virol 2000,74(24),11619-11625","journal-title":"J Virol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.virol.2007.02.025","volume":"364","author":"Risatti G.R.","year":"2007","unstructured":"Risatti G.R.; Holinka L.G.; Fernandez Sainz I.; Carrillo C.; Kutish G.F.; Lu Z.; Zhu J.; Rock D.L.; Borca M.V.; Mutations in the carboxyl terminal region of E2 glycoprotein of classical swine fever virus are responsible for viral attenuation in swine. Virology 2007,364(2),371-382","journal-title":"Virology"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.tibtech.2014.02.001","volume":"32","author":"Hanke A.T.","year":"2014","unstructured":"Hanke A.T.; Ottens M.; Purifying biopharmaceuticals: knowledge-based chromatographic process development. Trends Biotechnol 2014,32(4),210-220","journal-title":"Trends Biotechnol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471140864.ps0601s80","volume":"80","author":"Wingfield P.T.","year":"2015","unstructured":"Wingfield P.T.; Overview of the purification of recombinant proteins. Curr Protoc Protein Sci 2015,80,1-6, 35","journal-title":"Curr Protoc Protein Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1089\/104303403322167984","volume":"14","author":"Transfiguracion J.","year":"2003","unstructured":"Transfiguracion J.; Jaalouk D.E.; Ghani K.; Galipeau J.; Kamen A.; Size-exclusion chromatography purification of high-titer vesicular stomatitis virus G glycoprotein-pseudotyped retrovectors for cell and gene therapy applications. Hum Gene Ther 2003,14(12),1139-1153","journal-title":"Hum Gene Ther"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/10826068.2014.995811","volume":"46","author":"Saito M.","year":"2016","unstructured":"Saito M.; Yoshitake T.; Okuyama T.; Separation and analysis of charged isomers of monoclonal immunoglobulin G by ceramic hydroxyapatite chromatography. Prep Biochem Biotechnol 2016,46(3),215-221","journal-title":"Prep Biochem Biotechnol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"10266","DOI":"10.1038\/srep10266","volume":"5","author":"Balaj L.","year":"2015","unstructured":"Balaj L.; Atai N.A.; Chen W.; Mu D.; Tannous B.A.; Breakefield X.O.; Skog J.; Maguire C.A.; Heparin affinity purification of extracellular vesicles. Sci Rep 2015,5,10266","journal-title":"Sci Rep"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.chroma.2014.02.016","volume":"1337","author":"Wellhoefer M.","year":"2014","unstructured":"Wellhoefer M.; Sprinzl W.; Hahn R.; Jungbauer A.; Continuous processing of recombinant proteins: integration of refolding and purification using simulated moving bed size-exclusion chromatography with buffer recycling. J Chromatogr A 2014,1337,48-56","journal-title":"J Chromatogr A"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1023\/A:1022109905487","volume":"68","author":"Liang J.F.","year":"2003","unstructured":"Liang J.F.; Zhen L.; Chang L.C.; Yang V.C.; A less toxic heparin antagonist--low molecular weight protamine. Biochemistry (Mosc) 2003,68(1),116-120","journal-title":"Biochemistry (Mosc)"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.drudis.2009.10.009","volume":"15","author":"Vlieghe P.","year":"2010","unstructured":"Vlieghe P.; Lisowski V.; Martinez J.; Khrestchatisky M.; Synthetic therapeutic peptides: science and market. Drug Discov Today 2010,15(1-2),40-56","journal-title":"Drug Discov Today"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nprot.2016.051","volume":"11","author":"Forli S.","year":"2016","unstructured":"Forli S.; Huey R.; Pique M.E.; Sanner M.F.; Goodsell D.S.; Olson A.J.; Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc 2016,11(5),905-919","journal-title":"Nat Protoc"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nrd1549","volume":"3","author":"Kitchen D.B.","year":"2004","unstructured":"Kitchen D.B.; Decornez H.; Furr J.R.; Bajorath J.; Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 2004,3(11),935-949","journal-title":"Nat Rev Drug Discov"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.2174\/156802607780906753","volume":"7","author":"Cavasotto C.N.","year":"2007","unstructured":"Cavasotto C.N.; Orry A.J.; Ligand docking and structure-based virtual screening in drug discovery. Curr Top Med Chem 2007,7(10),1006-1014","journal-title":"Curr Top Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1021\/ci900031y","volume":"49","author":"Tiwari R.","year":"2009","unstructured":"Tiwari R.; Mahasenan K.; Pavlovicz R.; Li C.; Tjarks W.; Carborane clusters in computational drug design: a comparative docking evaluation using AutoDock, FlexX, Glide, and Surflex. J Chem Inf Model 2009,49(6),1581-1589","journal-title":"J Chem Inf Model"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2174\/1568026615666150825142002","volume":"16","author":"Wang T.","year":"2016","unstructured":"Wang T.; Wu M.B.; Zhang R.H.; Chen Z.J.; Hua C.; Lin J.P.; Yang L.R.; Advances in computational structure-based drug design and application in drug discovery. Curr Top Med Chem 2016,16(9),901-916","journal-title":"Curr Top Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4142\/jvs.2017.18.3.307","volume":"18","author":"Li H.","year":"2017","unstructured":"Li H.; Yang J.; Bao D.; Hou J.; Zhi Y.; Yang Y.; Ji P.; Zhou E.; Qiao S.; Zhang G.; Development of an immunochromatographic strip for detection of antibodies against porcine reproductive and respiratory syndrome virus. J Vet Sci 2017,18(3),307-316","journal-title":"J Vet Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.chroma.2007.01.130","volume":"1146","author":"Liu F.F.","year":"2007","unstructured":"Liu F.F.; Wang T.; Dong X.Y.; Sun Y.; Rational design of affinity peptide ligand by flexible docking simulation. J Chromatogr A 2007,1146(1),41-50","journal-title":"J Chromatogr A"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ddtec.2006.09.004","volume":"3","author":"Tang Y.","year":"2006","unstructured":"Tang Y.; Zhu W.; Chen K.; Jiang H.; New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery. Drug Discov Today Technol 2006,3(3),307-313","journal-title":"Drug Discov Today Technol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1098\/rsta.2003.1197","volume":"361","author":"Pawson T.","year":"2003","unstructured":"Pawson T.; Organization of cell-regulatory systems through modular-protein-interaction domains. Philos Trans- Royal Soc, Math Phys Eng Sci 2003,361(1807),1251-1262","journal-title":"Philos Trans- Royal Soc, Math Phys Eng Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.sbi.2009.07.003","volume":"19","author":"Naider F.","year":"2009","unstructured":"Naider F.; Anglister J.; Peptides in the treatment of AIDS. Curr Opin Struct Biol 2009,19(4),473-482","journal-title":"Curr Opin Struct Biol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.copbio.2008.06.004","volume":"19","author":"Petsalaki E.","year":"2008","unstructured":"Petsalaki E.; Russell R.B.; Peptide-mediated interactions in biological systems: new discoveries and applications. Curr Opin Biotechnol 2008,19(4),344-350","journal-title":"Curr Opin Biotechnol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1074\/jbc.M411047200","volume":"280","author":"Jiang B.","year":"2005","unstructured":"Jiang B.; Liu W.; Qu H.; Meng L.; Song S.; Ouyang T.; Shou C.; A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2. J Biol Chem 2005,280(6),4656-4662","journal-title":"J Biol Chem"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bios.2016.08.031","volume":"87","author":"Hwang H.J.","year":"2017","unstructured":"Hwang H.J.; Ryu M.Y.; Park C.Y.; Ahn J.; Park H.G.; Choi C.; Ha S.D.; Park T.J.; Park J.P.; High sensitive and selective electrochemical biosensor: label-free detection of human norovirus using affinity peptide as molecular binder. Biosens Bioelectron 2017,87,164-170","journal-title":"Biosens Bioelectron"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1158\/0008-5472.CAN-05-3521","volume":"66","author":"Orlova A.","year":"2006","unstructured":"Orlova A.; Magnusson M.; Eriksson T.L.; Nilsson M.; Larsson B.; H&#xF6;id&#xE9;n-Guthenberg I.; Widstr&#xF6;m C.; Carlsson J.; Tolmachev V.; St&#xE5;hl S.; Nilsson F.Y.; Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res 2006,66(8),4339-4348","journal-title":"Cancer Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1002\/adma.201301646","volume":"25","author":"Adams B.L.","year":"2013","unstructured":"Adams B.L.; Finch A.S.; Hurley M.M.; Sarkes D.A.; Stratis-Cullum D.N.; Genetically engineered peptides for inorganics: study of an unconstrained bacterial display technology and bulk aluminum alloy. Adv Mater 2013,25(33),4585-4591","journal-title":"Adv Mater"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.tibtech.2011.01.004","volume":"29","author":"Vanhee P.","year":"2011","unstructured":"Vanhee P.; van der Sloot A.M.; Verschueren E.; Serrano L.; Rousseau F.; Schymkowitz J.; Computational design of peptide ligands. Trends Biotechnol 2011,29(5),231-239","journal-title":"Trends Biotechnol"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"W249","DOI":"10.1093\/nar\/gkr431","volume":"39","author":"London N.","year":"2011","unstructured":"London N.; Raveh B.; Cohen E.; Fathi G.; Schueler-Furman O.; Rosetta FlexPepDock web server high resolution modeling of peptide-protein interactions. Nucleic Acids Res 2011,39(Web Server issue),W249-W253","journal-title":"Nucleic Acids Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"W431","DOI":"10.1093\/nar\/gkv495","volume":"43","author":"Lee H.","year":"2015","unstructured":"Lee H.; Heo L.; Lee M.S.; Seok C.; GalaxyPepDock: a protein-peptide docking tool based on interaction similarity and energy optimization. Nucleic Acids Res 2015,43(W1),W431-435","journal-title":"Nucleic Acids Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"W419-24","DOI":"10.1093\/nar\/gkv456","volume":"43","author":"Kurcinski M.","year":"2015","unstructured":"Kurcinski M.; Jamroz M.; Blaszczyk M.; Kolinski A.; Kmiecik S.; CABS-dock web server for the flexible docking of peptides to proteins without prior knowledge of the binding site. Nucleic Acids Res 2015,43(W1),W419-24","journal-title":"Nucleic Acids Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pep.2016.05.013","volume":"216","author":"Morris J.","year":"2016","unstructured":"Morris J.; Jayanthi S.; Langston R.; Daily A.; Kight A.; McNabb D.S.; Henry R.; Kumar T.; Heparin-binding peptide as a novel affinity tag for purification of recombinant proteins. Protein Expr Purif 2016,216,93-103","journal-title":"Protein Expr Purif"},{"key":"ref=37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2016.02.011","author":"Lagoutte P.","year":"2016","unstructured":"Lagoutte P.; Mignon C.; Donnat S.; Stadthagen G.; Mast J.; Sodoyer R.; Lugari A.; Werle B.; Scalable chromatography-based purification of virus-like particle carrier for epitope based influenza A vaccine produced in Escherichia coli. J Virol Methods 2016","journal-title":"J Virol Methods"},{"key":"ref=38","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3591-8_3","author":"Hou S.","year":"2016","unstructured":"Hou S.; Shi L.; Lei H.; Biotin-streptavidin affinity purification of RNA-protein complexes assembled in vitro. Methods in Molecular Biology Vol. 1412.2016","journal-title":"Methods in Molecular Biology"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.sbi.2014.04.006","volume":"26","author":"Wood D.W.","year":"2014","unstructured":"Wood D.W.; New trends and affinity tag designs for recombinant protein purification. Curr Opin Struct Biol 2014,26,54-61","journal-title":"Curr Opin Struct Biol"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929866527666201103152100","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/187558\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929866527666201103152100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T18:50:58Z","timestamp":1660416658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/187558\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929866527666201103152100","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-07-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}